CURRENT USE AND OUTCOMES OF HEMATOPOIETIC STEM CELL TRANSPLANTATION: BRAZILIAN SUMMARY SLIDES - 2023

Abstract

The first hematopoietic stem cell transplantation (HSCT) program in Latin America started in
1979 at the federal university hospital in Curitiba, Paraná, Brazil. Over the years, the number
of centers performing transplants in our country has increased significantly generating the
need to know the results of this treatment modality. Understanding the HSCT scenario in
Brazil is still challenging, since not all Brazilian centers report data to the Center for International Blood and Marrow Research (CIBMTR). Despite the improvement in the number of
reporting centers over the past few years, infrastructure and trained data managers are still
lacking. The partnership between the Brazilian Cellular Therapy and Bone Marrow Transplant
Society (SBTMO) and the CIBMTR enabled the establishment of the Hematopoietic Stem Cell
Transplantation Brazilian Registry (HSCTBR), using the CIBMTR Data Back to Center (DBtC)
tool to retrieve Brazilian HSCT data in a standardized and organized way. Since then, it has
been possible to gather country-level data on HSCT demographics and transplant outcomes.
Between 2012 and 2022, complete information on 9,868 transplants were reported to the
CIBMTR from 40 Brazilian transplant centers. The consolidation of the HSCTBR using CIBMTR
infrastructure allowed the development and regular update of the Brazilian Summary Slides.
Despite the differences in the number of cases and follow-up time, the results in this study
were similar to those presented in the United States (US) Summary Slides. In this paper we
present the 2023 SBTMO-CIBMTR Summary Slides prepared by the SBTMO data managers
(GD-SBTMO).